Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37196452/ Authors Silvia Kochen 1 , Manuela Villanueva 1 , Liliana Bayarres 1 , Anilu Daza-Restrepo 1 , Silvia Gonzalez Martinez 1 , Silvia Oddo 2 Highlights Abstract Cannabidiol oil (CBD) has been approved as an anti-seizure medication for the treatment of uncommon types of epilepsy, occurring in children: Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous…